Skip to main content
Live · TradingView
Back to the NewsWire

Firstwordpharma

Published September 8, 2026 · Updated September 9, 2026

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B ...

Read the full story at Firstwordpharma

Clearmind is a clinical-stage neuroplastogens pharmaceutical biotech company focused on the discovery and development of non- hallucinogenic.

Surfaced by this Google Alert

  • Psychedelic biotech